191 related articles for article (PubMed ID: 10973132)
1. Detection of Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured atherosclerotic plaques.
Higuchi ML; Sambiase N; Palomino S; Gutierrez P; Demarchi LM; Aiello VD; Ramires JA
Braz J Med Biol Res; 2000 Sep; 33(9):1023-6. PubMed ID: 10973132
[TBL] [Abstract][Full Text] [Related]
2. Coinfection with Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured plaques associated with acute myocardial infarction.
Higuchi Mde L; Reis MM; Sambiase NV; Palomino SA; Castelli JB; Gutierrez PS; Aiello VD; Ramires JA
Arq Bras Cardiol; 2003 Jul; 81(1):12-22, 1-11. PubMed ID: 12908069
[TBL] [Abstract][Full Text] [Related]
3. [Mycoplasma pneumoniae and Chlamydia pneumoniae are associated to inflammation and rupture of the atherosclerotic coronary plaques].
Ramires JA; Higuchi Mde L
Rev Esp Cardiol; 2002; 55 Suppl 1():2-9. PubMed ID: 15626350
[TBL] [Abstract][Full Text] [Related]
4. Infectious agents in coronary atheromas: a possible role in the pathogenesis of plaque rupture and acute myocardial infarction.
Higuchi Mde L; Ramires JA
Rev Inst Med Trop Sao Paulo; 2002; 44(4):217-24. PubMed ID: 12219114
[TBL] [Abstract][Full Text] [Related]
5. Great amount of C.pneumoniae in ruptured plaque vessel segments at autopsy. A comparative study with stable plaques.
Higuchi Md; Castelli JB; Aiello VD; Palomino S; Reis MM; Sambiase NV; Fukasawa S; Bezerra HG; Ramires JA
Arq Bras Cardiol; 2000 Feb; 74(2):149-51. PubMed ID: 10904288
[TBL] [Abstract][Full Text] [Related]
6. A role for archaeal organisms in development of atherosclerotic vulnerable plaques and myxoid matrices.
Higuchi ML; Santos MH; Roggério A; Kawakami JT; Bezerra HG; Canzian M
Clinics (Sao Paulo); 2006 Oct; 61(5):473-8. PubMed ID: 17072447
[TBL] [Abstract][Full Text] [Related]
7. Co-infection ratios versus inflammation, growth factors and progression of early atheromas.
Higuchi ML; Góis JM; Reis MM; Higuchi-Dos-Santos MH; Diament J; Sousa JM; Ramires JA; Oliveira SA
APMIS; 2006 May; 114(5):338-44. PubMed ID: 16725009
[TBL] [Abstract][Full Text] [Related]
8. [Rupture of the atherosclerotic plaque: is Chlamydia pneumoniae a possible agent?].
Fazio G; Sutera L; Zito R; Cascio C; Briguglia D; Taormina S; Giammanco A; Assennato P; Novo S
G Ital Cardiol (Rome); 2006 Dec; 7(12):809-14. PubMed ID: 17294605
[TBL] [Abstract][Full Text] [Related]
9. [Persistence of Chlamydia pneumoniae in coronary plaque tissue. A contribution to infection and immune hypothesis in unstable angina pectoris].
Bauriedel G; Andrié R; Likungu JA; Welz A; Braun P; Welsch U; Lüderitz B
Dtsch Med Wochenschr; 1999 Nov; 124(47):1408-13. PubMed ID: 10605420
[TBL] [Abstract][Full Text] [Related]
10. The role of atypical organisms in asthma.
Daian CM; Wolff AH; Bielory L
Allergy Asthma Proc; 2000; 21(2):107-11. PubMed ID: 10791112
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of Chlamydophila pneumoniae, Mycoplasma pneumoniae, Cytomegalovirus, and Epstein-Barr virus in atherosclerotic coronary arteries, nonrheumatic calcific aortic and rheumatic stenotic mitral valves by polymerase chain reaction.
Bayram A; Erdoğan MB; Ekşi F; Yamak B
Anadolu Kardiyol Derg; 2011 May; 11(3):237-43. PubMed ID: 21466993
[TBL] [Abstract][Full Text] [Related]
12. The presence of Chlamydia pneumoniae in atherosclerotic plaques--a report of three cases of ischaemic heart disease.
Walski M; Podsiadły E; Walczak E; Celary-Walska R; Dabrowski M; Tylewska-Wierzbanowska S; Ruzyłło W; Witkowski A; Słysz A
Pol J Pathol; 1999; 50(2):93-7. PubMed ID: 10481533
[TBL] [Abstract][Full Text] [Related]
13. Chlamydia pneumoniae in atherosclerotic tissue.
Taylor-Robinson D; Thomas BJ
J Infect Dis; 2000 Jun; 181 Suppl 3():S437-40. PubMed ID: 10839732
[TBL] [Abstract][Full Text] [Related]
14. [Chlamydia pneumoniae and cardiovascular diseases].
Rajtar R; Malczewska-Malec M; Kloch M; Kolasińska-Kloch W
Przegl Lek; 2004; 61(3):165-9. PubMed ID: 15518326
[TBL] [Abstract][Full Text] [Related]
15. Search for agents causing atypical pneumonia in HIV-positive patients by inhibitor-controlled PCR assays.
Tarp B; Jensen JS; Ostergaard L; Andersen PL
Eur Respir J; 1999 Jan; 13(1):175-9. PubMed ID: 10836344
[TBL] [Abstract][Full Text] [Related]
16. [Infection and coronary atherosclerosis: the role Chlamydia pneumonia].
Paz M; de Otero J; Codinach P; Ferrer-Ruscalleda F; Gayà M; Ibernón M
Rev Esp Cardiol; 1998 Nov; 51(11):857-63. PubMed ID: 9859707
[TBL] [Abstract][Full Text] [Related]
17. Microorganisms and valve tissue/ demonstration of Chlamydophila pneumoniae, Mycoplasma pneumoniae, Cytomegalovirus, and Epstein-Barr virus in atherosclerotic coronary arteries, nonrheumatic calcific aortic and rheumatic stenotic mitral valves by polymerase chain reaction.
Davutoğlu V; Ercan S; Oylumlu M
Anadolu Kardiyol Derg; 2011 Sep; 11(6):564; author reply 564-5. PubMed ID: 21827993
[No Abstract] [Full Text] [Related]
18. Prevalence of Chlamydia pneumoniae in the atherosclerotic plaque of patients with unstable angina and its relation with serology.
Zamorano J; Suarez A; Garcia Tejada J; Culebras E; Castañón J; Picazo J; Moreno R; Sanchez-Harguindey L
Int J Cardiol; 2003 Jun; 89(2-3):273-9. PubMed ID: 12767552
[TBL] [Abstract][Full Text] [Related]
19. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group.
Ramirez JA
Ann Intern Med; 1996 Dec; 125(12):979-82. PubMed ID: 8967709
[TBL] [Abstract][Full Text] [Related]
20. Low prevalence of Chlamydia pneumoniae in atherectomy specimens from patients with coronary heart disease.
Jantos CA; Nesseler A; Waas W; Baumgärtner W; Tillmanns H; Haberbosch W
Clin Infect Dis; 1999 May; 28(5):988-92. PubMed ID: 10452622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
